The Effect of Nasogastric Tube Placement on Complications in Patients With Small Bowel Obs
Background: Small bowel obstruction (SBO) is a surgical emergency where the normal continuous bowel movements are hindered and approximately 8000-9000 patients visit the emergency department every year in Sweden due to SBO. A minority of these have evidence of intestinal injury, warranting emergency surgery, while the
| Condition(s) | Small Bowel Obstruction, Intestinal Obstruction and Ileus |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Background: Small bowel obstruction (SBO) is a surgical emergency where the normal continuous bowel movements are hindered and approximately 8000-9000 patients visit the emergency department every year in Sweden due to SBO. A minority of these have evidence of intestinal injury, warranting emergency surgery, while the majority (70-90%) will have an initial plan for non-operative management with a nasogastric tube (NGT), placed to alleviate gastric pressure, reduce pain and prevent complications like aspiration pneumonia. The effectiveness of NGT in patients with SBO to prevent complications is unclear, with current data from observational data indicating increased risk of pneumonia in patients treated with NGT. Objective: To assess whether deferring the placement of a NGT in subjects with |
| Who can participate | Inclusion Criteria: * Small bowel obstruction diagnosed on Computer Tomography Exclusion Criteria: * Nasogastric Tube already places * Amyotrophic lateral sclerosis * Cerebral palsy * Dementia * Parkinson's disease * Multiple Sclerosis * Previous stroke with documented persistent dysphagia * Planned for urgent surgery * Acute Massive Gastric Dilatation * Gastric outlet obstruction * Fundoplicatio/Inability to vomit * Signs of pneumonia/pneumonitis on initial diagnostic CT |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University Hospital, Linkoeping |
| Locations | Linköping, Sweden; Motala, Sweden; Värnamo, Sweden |
| Start date | 2026-05-27 |
| NCT ID | NCT07574515 |
| Official listing | https://clinicaltrials.gov/study/NCT07574515 |